• Policy
• Label for rosuvastatin to change following ticagrelor
• by Lee, Hye-Kyung Nov 21, 2022 05:56am

• Policy
• Public policy fee for severely ill children is implemented
• by Kim, Jung-Ju Nov 21, 2022 05:56am

• Policy
• The budget for Paxlovid's SE relief will be prepared
• by Lee, Jeong-Hwan Nov 18, 2022 06:04am

• Policy
• Quick diagnosis is essential for Hepatitis C
• by Nov 18, 2022 06:03am

• Policy
• Budget increase for drugs and vaccines under NA review
• by Lee, Jeong-Hwan Nov 17, 2022 05:54am

• Policy
• Use of Evusheld extended to the severely immunocompromised
• by Kim, Jung-Ju Nov 16, 2022 06:10am

• Policy
• Negotiations on Strepto, concluded in the early 20% range
• by Lee, Tak-Sun Nov 15, 2022 05:39am

• Policy
• The vaccine fund will be increased by ₩40 billion
• by Lee, Jeong-Hwan Nov 14, 2022 06:07am

• Policy
• Some companies give up negotiations to recover Strepto
• by Lee, Tak-Sun Nov 11, 2022 05:51am

• Policy
• Will expedited listing be possible within the year?
• by Lee, Tak-Sun Nov 10, 2022 05:46am